본문 바로가기
KERD
논문KCI 등재

Rates of Fecal Transmission of Extended-Spectrum β-Lactamase-Producing and Carbapenem-Resistant Enterobacteriaceae Among Patients in Intensive Care Units in Korea

이지영|정승원|송원근|김상일|김재석|박연준|유진경|김자영|박강균
대한진단검사의학회 (Korean Society For Laboratory Medicine)|2014.01|Annals of Laboratory Medicine|제34권 제1호|pp. 20-25

1

조회

0

다운로드

7

인용

0

참고문헌

키워드

TransmissionColonizationCRECTX-MRectal swabESBL-E
주제분류병리학

초록

Background: We investigated the rates of fecal transmission of extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae (ESBL-E) and carbapenem-resistant Enterobacteriaceae (CRE) among patients admitted to intensive care units (ICUs). Methods: From June to August 2012, rectal cultures were acquired from all patients at ICU admission. For patients not carrying ESBL-E or CRE at admission, follow-up cultures were performed to detect acquisition. A chromogenic assay was used to screen for ESBL-E and CRE. Bacterial species identification and antibiotic susceptibility tests were performed using the Vitek 2 system (bioMérieux, France). ESBL genotypes were determined by PCR, and clonal relatedness of the isolates was assessed by pulsed-field gel electrophoresis. Results: Out of 347 ICU admissions, 98 patients were found to be carriers of ESBL-E (28.2%, 98/347). Follow-up cultures were acquired from 91 of the patients who tested negative for ESBL-E at admission; the acquisition rate in this group was 12.1% (11/91), although none was a nosocomial transmission. For CRE, the prevalence of fecal carriage was 0.3% (1/347), and the acquisition rate was 2.9% (4/140). None of the CRE isolates were carbapenemase-producers. Conclusions: The high prevalence of ESBL-E carriage on admission (28.2%), coupled with rare nosocomial transmission and the very low carriage rate of CRE (0.3%), challenge the routine use of active surveillance in non-epidemic settings. Nevertheless, passive sur- veillance measures, such as rapid and accurate screening of clinical specimens, will be critical for controlling the spread of CRE.

Abstract

Background: We investigated the rates of fecal transmission of extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae (ESBL-E) and carbapenem-resistant Enterobacteriaceae (CRE) among patients admitted to intensive care units (ICUs). Methods: From June to August 2012, rectal cultures were acquired from all patients at ICU admission. For patients not carrying ESBL-E or CRE at admission, follow-up cultures were performed to detect acquisition. A chromogenic assay was used to screen for ESBL-E and CRE. Bacterial species identification and antibiotic susceptibility testsㅌ were performed using the Vitek 2 system (bioMérieux, France). ESBL genotypes were determined by PCR, and clonal relatedness of the isolates was assessed by pulsed-field gel electrophoresis. Results: Out of 347 ICU admissions, 98 patients were found to be carriers of ESBL-E (28.2%, 98/347). Follow-up cultures were acquired from 91 of the patients who tested negative for ESBL-E at admission; the acquisition rate in this group was 12.1% (11/91), although none was a nosocomial transmission. For CRE, the prevalence of fecal carriage was 0.3% (1/347), and the acquisition rate was 2.9% (4/140). None of the CRE isolates were carbapenemase-producers. Conclusions: The high prevalence of ESBL-E carriage on admission (28.2%), coupled with rare nosocomial transmission and the very low carriage rate of CRE (0.3%), challenge the routine use of active surveillance in non-epidemic settings. Nevertheless, passive sur- veillance measures, such as rapid and accurate screening of clinical specimens, will be critical for controlling the spread of CRE.

참고문헌 (38)

  1. Kliebe C, "Evolution of plasmid-coded resistance to broad-spectrum cephalosporins", Antimicrob Agents Chemother, 28, pp.302~307 (1985)
  2. Drieux L, "Increase in hospital-acquired bloodstream infections caused by extended spectrum beta-lactamase-producing Escherichia coli in a large French teaching hospital", Eur J Clin Microbiol Infect Dis, 28, pp.491~498 (2009)
  3. "Antimicrobial resistance surveillance in Europe 2010. Annual report of the European antimicrobial resistance surveillance network (EARS-Net)" (2011)[URL]
  4. Munoz-Price LS, "Successful eradication of a monoclonal strain of Klebsiella pneumoniae during a K. pneumoniae carbapenemase-producing K. pneumoniae outbreak in a surgical intensive care unit in Miami, Florida", Infect Control Hosp Epidemiol, 31, pp.1074~1077 (2010)
  5. Karah N, "Emergence of OXA-carbapenemase- and 16S rRNA methylase-producing international clones of Acinetobacter baumannii in Norway", J Med Microbiol, 60, pp.515~521 (2011)
  6. Troché G, "Detection and treatment of antibiotic-resistant bacterial carriage in a surgical intensive care unit: a 6-yr prospective survey", Infect Control Hosp Epidemiol, 26, pp.161~165 (2005)
  7. Ko KS, "Prevalence and characterization of extended-spectrum beta-lactamase-producing Enterobacteriaceae isolated in Korean hospitals", Diagn Microbiol Infect Dis, 61, pp.453~459 (2008)
  8. Song W, "CTX-M-14 and CTX-M-15 enzymes are the dominant type of extended-spectrum beta-lactamase in clinical isolates of Escherichia coli from Korea", JOURNAL OF MEDICAL MICROBIOLOGY, 58, pp.261~266 (2009), SOC GENERAL MICROBIOLOGY
  9. Hoban DJ, "Antimicrobial susceptibility of global inpatient urinary tract isolates of Escherichia coli: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program: 2009-2010", Diagn Microbiol Infect Dis, 70, pp.507~511 (2011)
  10. David M. Livermore, "Current Epidemiology and Growing Resistance of Gram- Negative Pathogens", The Korean Journal of Internal Medicine, 27(2), pp.128~142 (2012), 대한내과학회
  11. Thouverez M, "Control of Enterobacteriaceae producing extended-spectrum beta-lactamase in intensive care units: rectal screening may not be needed in non-epidemic situations", Infect Control Hosp Epidemiol, 25, pp.838~841 (2004)
  12. Azim A, "Epidemiology of bacterial colonization at intensive care unit admission with emphasis on extended-spectrum beta-lactamase- and metallo-beta-lactamase-producing Gram-negative bacteria--an Indian experience", J Med Microbiol, 59, pp.955~960 (2010)
  13. Centers for Disease Control and Prevention (CDC)., "Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities", MMWR Morb Mortal Wkly Rep, 58, pp.256~260 (2009)
  14. Day KM, "Prevalence and molecular characterization of Enterobacteriaceae producing NDM-1 carbapenemase at a military hospital in Pakistan and evaluation of two chromogenic media", Diagn Microbiol Infect Dis, 75, pp.187~191 (2013)
  15. Clinical and Laboratory Standards Institute, "Performance standards for antimicrobial susceptibility testing. Twenty-second Informational supplement, M100-S22", Clinical and Laboratory Standards Institute, ~ (2012)
  16. Song W, "Use of boronic acid disk methods to detect the combined expression of plasmid-mediated AmpC beta-lactamases and extended-spectrum beta-lactamases in clinical isolates of Klebsiella spp., Salmonella spp., and Proteus mirabilis", DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 57, pp.315~318 (2007), ELSEVIER SCIENCE INC
  17. Perry JD, "Prevalence of faecal carriage of Enterobacteriaceae with NDM-1 carbapenemase at military hospitals in Pakistan, and evaluation of two chromogenic media", J Antimicrob Chemother, 66, pp.2288~2294 (2011)
  18. Anderson KF, "Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae", J Clin Microbiol, 45, pp.2723~2725 (2007)
  19. Woodford N, "Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum β-lactamases", J Antimicrob Chemother, 57, pp.154~155 (2006)
  20. Kim J, "Survey of Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases: prevalence of SHV-12 and SHV-2a in Korea", J Clin Microbiol, 36, pp.1446~1449 (1998)
  21. Lee K, "Diversity of TEM-52 extended-spectrum beta-lactamase-producing non-typhoidal Salmonella isolates in Korea", J Antimicrob Chemother, 52, pp.493~496 (2003)
  22. Poirel L, "Characterization of Class 1 integrons from Pseudomonas aeruginosa that contain the bla (VIM-2) carbapenem-hydrolyzing beta-lactamase gene and of two novel aminoglycoside resistance gene cassettes", Antimicrob Agents Chemother, 45, pp.546~552 (2001)
  23. Arakawa Y, "Convenient test for screening metallo-beta-lactamase-producing gram-negative bacteria by using thiol compounds", J Clin Microbiol, 38, pp.40~43 (2000)
  24. Bradford PA, "Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 β-lactamases in New York City", Clin Infect Dis, 39, pp.55~60 (2004)
  25. Yong D, "Characterization of a new metallo-β-lactamase gene, bla (NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 form India", Antimicrob Agents Chemother, 53, pp.5046~5054 (2009)
  26. Tenover FC, "Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing", J Clin Microbiol, 33, pp.2233~2239 (1995)
  27. Ko YJ, "Fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in Korean community and hospital settings", Infection, 41, pp.9~13 (2013)
  28. Razazi K, "Clinical impact and risk factors for colonization with extended-spectrum β-lactamase-producing bacteria in the intensive care unit", Intensive Care Med, 38, pp.1769~1778 (2012)
  29. Friedmann R, "Prospective evaluation of colonization with extended-spectrum β-lactamase (ESBL)-producing enterobacteriaceae among patients at hospital admission and of subsequent colonization with ESBL-producing enterobacteriaceae among patients during hospitalization", Infect Control Hosp Epidemiol, 30, pp.534~542 (2009)
  30. Coque TM, "Dissemination of clonality related Escherichia coli strains expressing extended-spectrum β-lactamase CTX-M-15", Emerg Infect Dis, 14, pp.195~200 (2008)
  31. Nicolas-Chanoine MH, "Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15", J Antimicrob Chemother, 61, pp.273~281 (2008)
  32. Tschudin-Sutter S, "Rate of transmission of extended-spectrum β-lactamase-producing enterobacteriaceae without contact isolation", Clin Infect Dis, 55, pp.1505~1511 (2012)
  33. Rodríguez-Baño J, "Faecal carriage of extended-spectrum β-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology", J Antimicrob Chemother, 62, pp.1142~1149 (2008)
  34. Goddard S, "The efficacy of infection control interventions in reducing the incidence of extended-spectrum β-lactamase-producing Enterobacteriaceae in the nonoutbreak setting: a systematic review", Am J Infect Control, 39, pp.599~601 (2011)
  35. "2011 Epidemiological report" (2013)[URL]
  36. Goren MG, "Transfer of carbapenem-resistant plasmid from Klebsiella pneumoniae ST258 to Escherichia coli in patient", Emerg Infect Dis, 16, pp.1014~1017 (2010)
  37. Mathers AJ, "Molecular dissection of an outbreak of carbapenem-resistant enterobacteriaceae reveals Intergenus KPC carbapenemase transmission through a promiscuous plasmid", MBio, 2, pp.00204~00211 (2011)
  38. Kim SY, "Characteristics of carbapenem-resistant Enterobacteriaceae isolates from Korea", Diagn Microbiol Infect Dis, 76, pp.486~490 (2013)

관련 논문AI추천

Prevalence and Risk Factors for Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae Colonization in Intensive Care UnitsBanseok Kim, Kyung-Won Lee, Yoon Soo Park, Young Ah Kim, Young Hee Seo대한진단검사의학회 · Annals of Laboratory Medicine2020 · 제40권 제2호Surveillance of Extended-Spectrum β-Lactamase-producing Enterobacteriaceae Carriage in a Japanese Intensive Care Unit: a Retrospective AnalysisAtsushi Togawa, Hiroyasu Ishikura, Kota Hoshino, Norihiko Matsumoto, Takeshi Nishida, Yasumasa Kawano, Yuhei Irie대한중환자의학회 · Acute and Critical Care2016 · 제31권 제4호Outbreak of Imipenemase-1-Producing Carbapenem-Resistant Klebsiella pneumoniae in an Intensive Care Unit김제훈, 박지영, 양희영, 유정식, 이영희, 이진영대한중환자의학회 · Acute and Critical Care2017 · 제32권 제1호Xpert CARBA-R Assay for the Detection of Carbapenemase-Producing Organisms in Intensive Care Unit Patients of a Korean Tertiary Care Hospital김도균, 김명숙, 김형선, 용동은, 이경원, 전종수, 정석훈, 최준용, Naina Pinto, Roshan D’Souza대한진단검사의학회 · Annals of Laboratory Medicine2016 · 제36권 제2호The Rate of Acquisition of Carbapenemase-Producing Enterobacteriaceae among Close Contact Patients Depending on Carbapenemase Enzymes곽선희, 김미나, 김성한, 박정완, 정지원, 최상호, Hye-Suk Choi, Jeong-Young Lee, Min-Jee Hong, Young-Ju Lim대한감염학회 · Infection and Chemotherapy2020 · 제52권 제1호지역사회 기질확장성 베타락타메이즈 생성 대장균의 확산 상황에서 집단발생이 없는 중환자실 내원환자의 적극적 감염감시 배양의 유용성박윤수대한임상미생물학회 · Annals of Clinical Microbiology2018 · 제21권 제2호

이 간행물의 다른 논문 (16건)

Assessment of Therapeutic Drug Monitoring of Vancomycin in Elderly Patients According to New Guidelines홍기숙, 오세진, 정화순, 공경애, 이은정, 최희정, 이미애pp. 1-6Quantification of Human Plasma-Busulfan Concentration by Liquid Chromatography-Tandem Mass Spectrometry전용범, 송정한, 장인진, 유경상, 강형진, 임경수, 임민규, 송상훈, 홍수지, 이지원, 한민제, 문수영pp. 7-14Comparison of ChromID Agar and Clostridium difficile Selective Agar for Effective Isolation of C. difficile from Stool Specimens이은주, 신보문pp. 15-19Early Detection of Mycobacteria Using a Novel Hydrogel Culture Method이은엽, 박병규, 장철훈, 황상현, 김창기, 장미희, 김신영, 김성수pp. 26-30The Drug Resistance Profile of Mycobacterium abscessus Group Strains from Korea김희진, 김설희, 유희경, 박영길, 김창기, 고원중, 이승헌pp. 31-37
원문 보기